Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 20 May 2024 15:03:38 +0200Fri, 12 Apr 2024 17:26:00 +0200Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/darzalexHuman medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 2, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/darzalexFri, 12 Apr 2024 17:26:00 +0200Human medicineDarzalex : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4077-steps-after_en_0.pdfDarzalex : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-4077-steps-after_en_0.pdfFri, 12 Apr 2024 17:19:00 +0200Human medicine